Cholesterol may not be the only lipid involved in trans fat-driven cardiovascular disease
Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more ...
Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
SLN ("Silence" or "the Company"), a global clinical stage biotechnology company committed to transforming people's lives by silencing diseases ...
Qatar Tribune9h
MoPH launches groundbreaking national action plan to tackle obesity, diabetes, and ASCVD risks
DOHA: The Ministry of Public Health (MoPH) has launched Qatar's National Action Plan on Obesity, Diabetes, and Modifiable ...
Silence Therapeutics plc: Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
SLN ("Silence" or "the Company"), a global clinical stage biotechnology company committed to transforming people's lives by silencing diseases through precision engineered ...